UBS AM’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.37M Buy
635,260
+1,159
+0.2% +$14.5K ﹤0.01% 1373
2025
Q4
$7.25M Buy
634,101
+27,833
+5% +$327K ﹤0.01% 1278
2025
Q3
$7.69M Sell
606,268
-308,963
-34% -$4.48M ﹤0.01% 1171
2025
Q2
$14.5M Buy
915,231
+322,210
+54% +$4.82M ﹤0.01% 1171
2025
Q1
$8.86M Buy
593,021
+41,579
+8% +$737K ﹤0.01% 1284
2024
Q4
$10.5M Buy
551,442
+65,308
+13% +$1.38M ﹤0.01% 1231
2024
Q3
$13.2M Sell
486,134
-153,846
-24% -$3.93M ﹤0.01% 1111
2024
Q2
$15.9M Buy
639,980
+66,416
+12% +$1.9M ﹤0.01% 953
2024
Q1
$19M Sell
573,564
-44,853
-7% -$1.53M 0.01% 801
2023
Q4
$22M Sell
618,417
-336,958
-35% -$10.7M 0.01% 747
2023
Q3
$32.6M Sell
955,375
-208,116
-18% -$7.91M 0.01% 663
2023
Q2
$45.7M Hold
1,163,491
0.02% 583
2023
Q1
$45.7M Sell
1,163,491
-22,958
-2% -$843K 0.02% 583
2022
Q4
$37.8M Sell
1,186,449
-28,585
-2% -$862K 0.02% 619
2022
Q3
$34.4M Sell
1,215,034
-37,204
-3% -$1.27M 0.02% 631
2022
Q2
$44.7M Sell
1,252,238
-7,559
-0.6% -$306K 0.02% 572
2022
Q1
$62M Buy
1,259,797
+28,800
+2% +$1.52M 0.03% 566
2021
Q4
$68.7M Sell
1,230,997
-19,775
-2% -$1.09M 0.03% 584
2021
Q3
$72.6M Buy
1,250,772
+7,167
+0.6% +$442K 0.03% 532
2021
Q2
$78.7M Sell
1,243,605
-44,244
-3% -$2.91M 0.03% 499
2021
Q1
$82.2M Sell
1,287,849
-22,591
-2% -$1.31M 0.04% 473
2020
Q4
$68.6M Buy
1,310,440
+92,908
+8% +$4.58M 0.03% 500
2020
Q3
$53.2M Buy
1,217,532
+8,669
+0.7% +$383K 0.03% 506
2020
Q2
$53.3M Sell
1,208,863
-97,115
-7% -$4.11M 0.03% 467
2020
Q1
$50.7M Buy
1,305,978
+155,740
+14% +$7.94M 0.04% 432
2019
Q4
$65.1M Buy
1,150,238
+51,310
+5% +$2.86M 0.04% 460
2019
Q3
$58.6M Buy
1,098,928
+122,445
+13% +$6.58M 0.04% 469
2019
Q2
$57M Buy
976,483
+205,449
+27% +$11M 0.04% 471
2019
Q1
$38.2M Buy
771,034
+43,396
+6% +$1.91M 0.03% 568
2018
Q4
$27.1M Buy
727,638
+5,339
+0.7% +$194K 0.02% 633
2018
Q3
$27.3M Sell
722,299
-13,517
-2% -$563K 0.02% 672
2018
Q2
$32.2M Sell
735,816
-8,419
-1% -$395K 0.02% 649
2018
Q1
$37.4M Buy
744,235
+110,350
+17% +$6.5M 0.03% 589
2017
Q4
$41.7M Sell
633,885
-23,416
-4% -$1.49M 0.04% 511
2017
Q3
$39.3M Sell
657,301
-24,117
-4% -$1.43M 0.04% 509
2017
Q2
$44.2M Sell
681,418
-343,578
-34% -$21.7M 0.04% 453
2017
Q1
$64M Buy
1,024,996
+40,816
+4% +$2.46M 0.07% 327
2016
Q4
$56.8M Buy
984,180
+49,439
+5% +$2.92M 0.06% 334
2016
Q3
$55.6M Buy
934,741
+353,109
+61% +$21.7M 0.06% 337
2016
Q2
$36.1M Buy
581,632
+8,309
+1% +$511K 0.04% 456
2016
Q1
$35.3M Buy
573,323
+207,087
+57% +$12.2M 0.04% 454
2015
Q4
$22.3M Sell
366,236
-78,329
-18% -$4.66M 0.03% 636
2015
Q3
$22.5M Sell
444,565
-14,052
-3% -$748K 0.02% 642
2015
Q2
$23.6M Buy
458,617
+37,096
+9% +$1.92M 0.02% 661
2015
Q1
$21.4M Sell
421,521
-22,939
-5% -$1.18M 0.02% 686
2014
Q4
$23.7M Sell
444,460
-3,041
-0.7% -$155K 0.02% 652
2014
Q3
$20.4M Buy
447,501
+4,758
+1% +$224K 0.02% 676
2014
Q2
$21M Buy
442,743
+2,465
+0.6% +$115K 0.02% 663
2014
Q1
$20.3M Buy
440,278
+25,879
+6% +$1.2M 0.02% 665
2013
Q4
$20.1M Sell
414,399
-4,048
-1% -$189K 0.02% 636
2013
Q3
$18.2M Buy
418,447
+25,030
+6% +$1.07M 0.02% 638
2013
Q2
$16.1M Buy
+393,417
New +$16.4M 0.02% 638

Other funds holding XRAY

UBS AM's XRAY Position: Q1 2026 in Review

UBS AM increased its Dentsply Sirona (XRAY) stake by 0.18% in Q1 2026, buying an estimated $14.5K and bringing the position to 635,260 shares worth $7.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

UBS AM first reported a position in XRAY in Q2 2013 and has held it in 52 quarters since. The position peaked at $82.2M in Q1 2021. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • UBS AM held 635,260 shares of Dentsply Sirona worth $7.37M as of Q1 2026.
  • UBS AM bought 1,159 Dentsply Sirona shares in Q1 2026, an estimated $14.5K.
  • Dentsply Sirona made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1373 holding.
  • UBS AM first reported a position in Dentsply Sirona in Q2 2013 and has held it in 52 quarters since.
  • UBS AM's Dentsply Sirona position peaked at $82.2M in Q1 2021.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.